Medical devices
FDA alerts customers to B. Braun Caresite device use instructions
Inspect Caresite Micro devices after disconnection and replace them if leakage, backflow or a valve that appears to remain open is observed.
The FDA issued an early alert after B. Braun Medical Inc. sent an urgent correction letter to affected customers recommending updated instructions for its Caresite Micro Luer Access Devices. The company said an internal piston can remain depressed after a male luer connector is disconnected, leaving the valve open. B. Braun confirmed the absence of silicone lubricant at the piston location and indicated a possible relationship between insufficient lubricant and the piston sticking.
The FDA said an open valve may allow blood, IV fluids or medications to leak and air to enter the fluid pathway, potentially causing blood loss, interruption or delay of therapy, medication loss, air embolism or microbial contamination. The alert advises inspecting devices after disconnection and replacing an affected device if leakage or backflow is observed, or if the valve appears to remain open. As of November 3, 2026, B. Braun had not reported serious injuries or deaths associated with the issue. The FDA is reviewing information and plans to update the alert as new information becomes available.


